Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Similar documents
Allcargo Logistics. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Bharat Petroleum Corporation

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Source: Company Data; PL Research

Britannia Industries

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Ashok Leyland. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Jindal Steel & Power

Hindustan Zinc. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Source: Company Data; PL Research

HDFC Standard Life Insurance

ICICI Prudential Life Insurance

Aurobindo Pharma. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Jindal Steel & Power

Ultratech Cement. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Larsen & Toubro. Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Colgate Palmolive. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Punjab National Bank

NIIT Technologies. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Bayer Cropscience (BYRCS IN)

Tata Steel. Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

LIC Housing Finance. Source: Company Data; PL Research

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Britannia Industries

Cadila Healthcare. Source: Company Data; PL Research

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals

FY20E FY21E FY20E FY21E

Cadila Healthcare. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

LIC Housing Finance. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Punjab National Bank

Pantaloon Retail India

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Dr. Reddy's Laboratories

SBI Life Insurance. Source: Company Data; PL Research

Gujarat State Fertilisers & Chemicals

Mindtree. Source: Company Data; PL Research.

Punjab National Bank

Glenmark Pharmaceuticals

Source: Company Data; PL Research

Larsen & Toubro (LT IN)

Transcription:

ILL loss hurts consolidated earnings growth May 14, 2018 Keyur Pandya keyurpandya@plindia.com +91 22 66322247 R Sreesankar rsreesankar@plindia.com +91 22 66322214 Rating Accumulate Price Rs140 Target Price Rs161 Implied Upside 15.0% Sensex 35,557 Nifty 10,807 (Prices as on May 14, 2018) Trading data Market Cap. (Rs bn) 32.8 Shares o/s (m) 233.6 3M Avg. Daily value (Rs m) 19.1 Major shareholders Promoters 61.78% Foreign 6.00% Domestic Inst. 16.98% Public & Other 15.24% Stock Performance (%) 1M 6M 12M Absolute (9.7) (11.5) (15.7) Relative (13.6) (19.4) (33.5) How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2019 7.0 1.0 597.3 2020 8.0 1.0 703.8 Price Performance (RIC: NAVN.BO, BB: NELI IN) (Rs) 200 150 100 50 0 May 17 Jul 17 Source: Bloomberg Sep 17 Nov 17 Jan 18 Mar 18 Navneet s (NELI) Q4FY18 standalone results were marginally below expectations with 1.8% YoY revenue growth and 10.6% YoY earnings contraction in a seasonally lean quarter. However, disappointment came from Indiannica Learning Ltd (ILL) which reported loss of Rs193.9m for FY18 impacted by operating deleverage, higher employee cost and lower revenue recognition due to change in accounting policy for sales return to the tune of ~Rs170m. Management is confident of (i) steady double digit growth in publishing aided by syllabus change in key states (ii) better stationery export visibility for FY19 and (iii) double digit growth coupled with improved margins with large expansion in titles in ILL ILL earnings impacted by operating deleverage & accounting policy: Indiannica Learning Ltd (ILL) reported loss of Rs193.4m in FY18 vs. net profit of Rs254m in FY17 (as consolidated only from Q4FY17) impacting the consolidated earnings. We believe that this is a one off accounting impact due to INDAS. However, management is confident of growth prospects at ILL with growth expectations upwards of 20% for FY19 on the back of expansion of product titles. Management is hopeful to reduce the losses in FY19E and to be profitable beyond FY20E Valuation and Outlook: In our view, NELI is well placed for growth opportunities over FY18 FY20E period considering ILL acquisition and the impending syllabus changes. Further strong Balance Sheet with negligible debt, superior return ratios upwards of 20%, strong generation of cash profits (~Rs2bn p.a.) and management bandwidth with proven track record give further comfort. NELI has been a value stock over the years with a payout ratio of ~50%. While we continue to remain optimistic on long term growth prospects of the company, near term outperformance may be lower with synergy with ILL being a key factor to watch out for. Downgrade to Accumulate with TP of Rs161 (from Rs198 earlier) valuing at 20x FY20E Key financials (Y/e March) 2017 2018 2019E 2020E Revenues (Rs m) 11,962 12,040 13,576 15,016 Growth (%) 25.5 0.7 12.8 10.6 EBITDA (Rs m) 2,981 2,225 2,624 2,977 PAT (Rs m) 1,946 1,275 1,629 1,877 EPS (Rs) 8.3 5.5 7.0 8.0 Growth (%) 65.9 (34.5) 27.8 15.3 Net DPS (Rs) 2.5 1.5 2.4 3.1 Profitability & Valuation 2017 2018 2019E 2020E EBITDA margin (%) 24.9 18.5 19.3 19.8 RoE (%) 26.7 17.6 20.4 20.9 RoCE (%) 21.9 12.7 14.7 15.1 EV / sales (x) 2.9 2.9 2.5 2.3 EV / EBITDA (x) 11.5 15.7 13.2 11.5 PE (x) 16.9 25.7 20.1 17.5 P / BV (x) 4.7 4.4 3.9 3.5 Net dividend yield (%) 1.8 1.1 1.7 2.2 Source: Company Data; PL Research Q4FY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Publishing expected to improve after a washout year : Publishing segment reported anaemic growth of 3% YoY in FY18, hurt by loss of sales on account of delay in publishing of 9 th grade text book by board in Maharashtra (As panic buying of books from small/regional players by students). However, management is confident to tackle similar situation going forward with reduced lead time. Management is confident of double digit business growth with syllabus change visibility for FY19 in Maharashtra (grade 1, 8, 10) and Gujarat (Grade 9 & 11). Stationery to perform well backed by better visibility in exports: Stationery revenue grew only 3.1% YoY in FY18 to Rs5bn impacted by (i) destocking by channel in H1FY18 due to GST implementation (ii) sluggish export growth after an abnormally high growth of 33% in FY17 and (iii) INR appreciation against USD. However management is expecting recovery in growth with better visibility in export orders for FY19E and pick up in domestic stationery demand post GST, especially for large organised players. Exhibit 1: Revised estimates to factor in slower growth in ILL Particulars Earlier estimates Revised estimates % revision FY19E FY20E FY19E FY20E FY19E FY20E Net sales (Rs m) 14,259 15,700 13,576 15,016 4.8% 4.4% Adj. PAT (Rs m) 1,935 2,123 1,629 1,877 15.8% 11.6% EPS (Rs) 8.3 9.1 7.0 8.0 15.8% 11.6% May 14, 2018 2

Exhibit 2: Q4FY18 Result Overview (Rs m) Y/e March Q4FY18* Q4FY17* YoY gr (%) Q3FY18* FY18 FY17 YoY gr (%) Net Sales 2,126 2,090 1.8 1,744 12,040 11,722 2.7 Expenditure Raw Materials 1,034 1,021 1.3 801 5,849 5,447 7.4 % of Net sales 48.6 48.9 45.9 48.6 46.5 Personnel 287 234 22.8 296 1,468 1,187 23.7 % of Net sales 13.5 11.2 16.9 12.2 10.1 Selling, dist & Other Exp 568 545 4.2 444 2,499 2,348 6.4 % of Net sales 26.7 26.1 25.4 20.8 20.0 Total Expenditure 1,888 1,799 5.0 1,540 9,816 8,981 9.3 EBITDA 238 290 (18.1) 205 2,225 2,741 (18.8) Margin (%) 11.2 13.9 (271)bps 11.7 18.5 23.4 (491)bps Depreciation 64 64 0.6 62 307 284 8.1 EBIT 174 226 (23.4) 143 1,918 2,457 (22.0) Interest 17 11 50.9 1 77 43 80.4 Other Income 79 29 173.6 44 260 223 16.3 PBT 235 244 (3.6) 186 2,100 2,638 (20.4) Tax 84 75 12.2 67 825 827 (0.2) Tax Rate (%) 35.9 30.8 36.1 39.3 31.3 Adjusted PAT 151 169 (10.6) 119 1,273 1,706 (25.4) Reported PAT 151 169 (10.6) 119 1,273 1,706 (25.4) * Quarterly numbers are on standalone basis Exhibit 3: Segmental Snapshot Y/e March Q4FY18* Q4FY17* YoY gr (%) Q3FY18* FY18 FY17 YoY gr (%) Segment Revenue Publishing Content 543 536 1.3 845 7,000 6,772 3.4 Stationery Products 1,578 1,553 1.6 893 5,010 4,860 3.1 Segment EBITDA Publishing Content 84 133 (36.8) 172 1,903 2,236 (14.9) Stationery Products 212 155 36.4 58 507 553 (8.3) EBITDA Margin Publishing Content 15.5% 24.8% (935)bps 20.3% 27.2% 33.0% (584)bps Stationery Products 13.4% 10.0% 342 bps 6.5% 10.1% 11.4% (126)bps * Quarterly numbers are on standalone basis May 14, 2018 3

Story in charts Exhibit 4: Publishing remains cash cow while Stationery leverages Brand Navneet Exhibit 5: Working capital requirement has inched up due to ILL & competition in stationery segment Publishing Division Stationery Division Inventory days Receivable days 20000 Creditor days WC Days (Rs m) 15000 10000 5000 250 200 150 100 50 193 178 183 203 0 FY15 FY16 FY17 FY18 FY19E FY20E FY15 FY16 FY17 FY18 Exhibit 6: Consistently high Dividend payout creates comfort (%) 80.0 70.0 60.0 50.0 40.0 30.0 20.0 47.0 48.4 48.4 Incluidng buyback of Rs591m in FY17 52.7 75.7 33.0 FY13 FY14 FY15 FY16 FY17 FY18 Exhibit 7: Strong balance sheet shows prudence Net Debt/Equity (x) 0.40 0.35 0.30 0.25 0.20 0.15 0.10 0.05 FY16 FY17E FY18E FY19E FY20E Exhibit 8: High return ratios & strong cash generation over the years RoAE (%) RoACE (%) Cash Profit (Rs m) Avg Cash Profit 30.0 2500 25.0 20.0 15.0 10.0 5.0 2000 1500 1000 500 Rs 1.9bn 0.0 FY15 FY16 FY17E FY18E FY19E FY20E 0 FY15 FY16 FY17 FY18 FY19E FY20E May 14, 2018 4

Income Statement (Rs m) Net Revenue 11,962 12,040 13,576 15,016 Raw Material Expenses 5,447 5,849 6,571 7,222 Gross Profit 6,515 6,191 7,005 7,793 Employee Cost 1,187 1,468 1,625 1,821 Other Expenses 2,348 2,499 2,756 2,996 EBITDA 2,981 2,225 2,624 2,977 Depr. & Amortization 284 307 348 365 Net Interest 43 77 85 87 Other Income 223 259 270 280 Profit before Tax 2,878 2,100 2,461 2,804 Total Tax 827 824 822 937 Profit after Tax 1,946 1,274 1,629 1,877 Ex Od items / Min. Int. (105) (1) (10) 10 Adj. PAT 1,946 1,275 1,629 1,877 Avg. Shares O/S (m) 233.6 233.6 233.6 233.6 EPS (Rs.) 8.3 5.5 7.0 8.0 Cash Flow Abstract (Rs m) C/F from Operations 773 759 1399 1525 C/F from Investing (771) (326) (185) (108) C/F from Financing (63) (119) (356) (544) Inc. / Dec. in Cash (61) 313 859 873 Opening Cash (15) (77) 237 1,095 Closing Cash (77) 237 1,095 1,968 FCFF 2 432 1,214 1,417 FCFE 1,807 1,026 1,256 1,511 Key Financial Metrics Growth Revenue (%) 25.5 0.7 12.8 10.6 EBITDA (%) 44.8 (25.4) 18.0 13.5 PAT (%) 62.6 (34.5) 27.8 15.3 EPS (%) 65.9 (34.5) 27.8 15.3 Profitability EBITDA Margin (%) 24.9 18.5 19.3 19.8 PAT Margin (%) 16.3 10.6 12.0 12.5 RoCE (%) 21.9 12.7 14.7 15.1 RoE (%) 26.7 17.6 20.4 20.9 Balance Sheet Net Debt : Equity 0.2 0.3 0.2 0.1 Net Wrkng Cap. (days) 183 165 297 296 Valuation PER (x) 16.9 25.7 20.1 17.5 P / B (x) 4.7 4.4 3.9 3.5 EV / EBITDA (x) 11.5 15.7 13.2 11.5 EV / Sales (x) 2.9 2.9 2.5 2.3 Earnings Quality Eff. Tax Rate 28.7 39.2 33.4 33.4 Other Inc / PBT 7.8 12.4 11.0 10.0 Eff. Depr. Rate (%) 7.8 7.7 8.0 7.9 FCFE / PAT 92.9 80.5 77.1 80.5. Balance Sheet Abstract (Rs m) Shareholder's Funds 6,938 7,520 8,464 9,486 Total Debt 1,594 2,253 2,403 2,630 Other Liabilities (1) 2 1 1 Total Liabilities 8,532 9,775 10,868 12,116 Net Fixed Assets 2,094 2,131 2,130 2,040 Goodwill 457 457 457 457 Investments 413 807 792 797 Net Current Assets 5,568 6,381 7,490 8,823 Cash & Equivalents 97 68 657 1,332 Other Current Assets 7,146 8,074 8,640 9,455 Current Liabilities 1,676 1,761 1,807 1,964 Other Assets Total Assets 8,532 9,775 10,868 12,117 Quarterly Financials (Rs m) Y/e March Q1FY18 Q2FY18 Q3FY18 Q4FY18 Net Revenue 5,638 1,834 1,744 2,126 EBITDA 1,624 281 205 238 % of revenue 28.8 15.3 11.7 11.2 Depr. & Amortization 53 56 62 64 Net Interest 26 16 1 17 Other Income 123 47 44 79 Profit before Tax 1,668 256 186 235 Total Tax 572 89 67 83 Profit after Tax 1,097 166 119 152 Adj. PAT 1,097 166 119 152 Key Operating Metrics Segment Revenues Publishing 6,139 6,402 7,235 7,958 Stationery 4,860 5,010 5,561 6,061 EBIDTA Publishing 2,270 2,113 2,387 2,626 Stationery 553 501 567 618. May 14, 2018 5

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 43.4% 44.2% 12.4% 0.0% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Keyur Pandya (Mcom, MBA Finance), Mr. R Sreesankar (B.Sc ), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Keyur Pandya (Mcom, MBA Finance), Mr. R Sreesankar (B.Sc ), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. May 14, 2018 6